157736-55-5 Usage
General Description
2-cyano-2-methylpropyl 4-methylbenzenesulfonate is a chemical compound that is also known by the trade name Tropsinone. It is commonly used as a synthetic intermediate in the production of pharmaceuticals and agrochemicals. 2-cyano-2-methylpropyl 4-methylbenzenesulfonate is a sulfonate ester, meaning it contains a sulfonyl group attached to a benzene ring, and a 2-cyano-2-methylpropyl group, which contains a nitrile functional group. The presence of the nitrile group makes this compound useful for its ability to undergo various chemical reactions, including nucleophilic substitution and reductive amination. 2-cyano-2-methylpropyl 4-methylbenzenesulfonate is a versatile chemical with applications in a wide range of industries.
Check Digit Verification of cas no
The CAS Registry Mumber 157736-55-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,7,3 and 6 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 157736-55:
(8*1)+(7*5)+(6*7)+(5*7)+(4*3)+(3*6)+(2*5)+(1*5)=165
165 % 10 = 5
So 157736-55-5 is a valid CAS Registry Number.
157736-55-5Relevant articles and documents
5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS
-
Page/Page column 90-91; 73, (2021/04/17)
Provided herein are compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, and R7 are defined herein. Also provided herein are pharmaceutical compositions comprising a compound of Formula (I) as well as the use of such compounds as M4 receptor agonists.
NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS
-
Paragraph 0657, (2013/10/07)
The present invention relates to compounds of general formula I, wherein the groups R1, R2 and m are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.
Benzamide derivatives and uses related thereto
-
Page/Page column 33, (2008/06/13)
Benzamide derivatives of formula I are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders:
